Zebrafish as a multimodal platforms for anti-inflammatory phytomedicine discovery and translation
Frontiers in Pharmacology · 25.03.2026 · 17
DOI: 10.3389/fphar.2026.1775366 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 25.03.2026. Verfasst von Xiaohui Tan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Subtropical Crops Research Institute, Guangxi Academy of Agricultural Sciences, Nanning, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 185 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangxi Academy of Agricultural Sciences.
Abstract (Originalsprache)
The clinical translation of plant-derived anti-inflammatory agents is hindered by the disconnect between high-throughput in vitro assays and low-throughput, costly mammalian models. This review posits the zebrafish ( Danio rerio ) not merely as an alternative model, but as a central integrating platform that bridge this translational chasm through multimodal technological convergence. We first synthesize how zebrafish inflammation models—established via chemical, physical, or infectious stimuli—enable rapid, whole-organism efficacy and safety profiling of phytochemicals. We then dissect the conserved molecuar circuitry (NF-κB, MAPK, Nrf2) through which standardized extracts and isolated compounds exert their anti-inflammatory effects, visualized dynamically in transgenic lines. Crucially, we move beyond descriptive cataloguing to critically evaluate the integration of zebrafish with microfluidics-enabled high-content screening, AI-driven phenotypic analytics, CRISPR/Cas9 gene editing, network pharmacology, and humanized xenograft models. We argue that this convergent multimodal strategy transforms zebrafish from a correlative screening tool into a predictive, mechanism-resolving, and patient-relevant avatar system. We conclude that zebrafish-centric platforms furnish a robust, mechanism-driven, and scalable framework to accelerate the discovery, mechanistic elucidation, and rational preclinical development of safer, multi-target phytotherapeutics, thereby catalyzing the evolution of plant-based medicine from empirical discovery to precision anti-inflammatory therapy guided by a systems-level, mechanism-driven paradigm. This framework positions zebrafish-centered platforms as a cornerstone of next-generation anti-inflammatory precision medicine.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Guangxi Subtropical Crops Research Institute, Guangxi Academy of Agricultural Sciences, Nanning, China.
- Guangxi Key Laboratory of Quality and Safety Control for Subtropical Fruits, Guangxi Subtropical Crops Research Institute, Nanning, China.
- Key Laboratory of Quality and Safety Control for Subtropical Fruit and Vegetable, Ministry of Agriculture and Rural Affairs, Nanning, China.
- Shanghai Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- College of Smart Agriculture, Yulin Normal University, Yulin, China.
Förderung
- Guangxi Academy of Agricultural Sciences
Zitieren
APA
Tan, X., Liu, H., Liang, F., & Chen, G. (2026). Zebrafish as a multimodal platforms for anti-inflammatory phytomedicine discovery and translation. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1775366
Vancouver
Tan X, Liu H, Liang F, Chen G. Zebrafish as a multimodal platforms for anti-inflammatory phytomedicine discovery and translation. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1775366
BibTeX
@article{Tan2026,
author = {Tan, Xiaohui and Liu, Huazhen and Liang, Fang and Chen, Ganlin},
title = {Zebrafish as a multimodal platforms for anti-inflammatory phytomedicine discovery and translation},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1775366}
}
EUVIMED